InvestorsHub Logo
Followers 37
Posts 1601
Boards Moderated 0
Alias Born 02/23/2020

Re: None

Wednesday, 06/29/2022 3:55:46 PM

Wednesday, June 29, 2022 3:55:46 PM

Post# of 162
NRSN is running hot on the RSI for good reason. NRSN is creating novel treatments. It's a new path forward in an otherwise, sort of maxed approach. It appears NRSN's contribution stabilizes the disease rather than continuing downward with standards of (current) care, if I understand this correctly. These results (and anytime they'll drop the alz and parkinsons biomarker data) are VERY significant for the neurological field in general. It appears NRSN's contribution is statistically significant and everyone loves that! Stabilizing! It's going to be bumpy but up we will go! They slammed the heck out of this today but there is absolutely no way, NRSN stays below $5-$6 soon. These findings are absolutely amazing in nature. The stock continues to trend and the shorts that love biotechs (especially) will be blown away once this thing really takes off. Those days are upon us now, and it'll only get louder and more exciting in here! They've got almost $14 million in cash and a pipeline that is PRODUCING! Tough to find these days; especially in such an important arena. They're improving terrible, debilitating diseases right before our eyes. Terrific findings reported and will continue! Best to all!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRSN News